Cargando…
Adverse Outcome Pathways can drive non-animal approaches for safety assessment
Adverse Outcome Pathways (AOPs) provide an opportunity to develop new and more accurate safety assessment processes for drugs and other chemicals, and may ultimately play an important role in regulatory decision making. Not only can the development and application of AOPs pave the way for the develo...
Autores principales: | Burden, Natalie, Sewell, Fiona, Andersen, Melvin E, Boobis, Alan, Chipman, J Kevin, Cronin, Mark T D, Hutchinson, Thomas H, Kimber, Ian, Whelan, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682468/ https://www.ncbi.nlm.nih.gov/pubmed/25943792 http://dx.doi.org/10.1002/jat.3165 |
Ejemplares similares
-
The future trajectory of adverse outcome pathways: a commentary
por: Sewell, Fiona, et al.
Publicado: (2018) -
Testing Chemical Safety: What Is Needed to Ensure the Widespread Application of Non-animal Approaches?
por: Burden, Natalie, et al.
Publicado: (2015) -
Palindromes drive the re-assortment in Influenza A
por: Zubaer, Abdullah, et al.
Publicado: (2011) -
The Root towards More Circularized Animal Production Systems: From Animal to Territorial Metabolism
por: De Rosa, Marcello, et al.
Publicado: (2021) -
The Relative Positioning of B and T Cell Epitopes Drives Immunodominance
por: Biavasco, Riccardo, et al.
Publicado: (2022)